AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 68 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $32,000 | -25.6% | 51,000 | 0.0% | 0.02% | -46.2% |
Q3 2019 | $43,000 | +26.5% | 51,000 | 0.0% | 0.04% | +25.8% |
Q2 2019 | $34,000 | -19.0% | 51,000 | 0.0% | 0.03% | -22.5% |
Q1 2019 | $42,000 | +133.3% | 51,000 | +363.6% | 0.04% | +122.2% |
Q4 2018 | $18,000 | -50.0% | 11,000 | 0.0% | 0.02% | -41.9% |
Q3 2018 | $36,000 | +44.0% | 11,000 | 0.0% | 0.03% | +55.0% |
Q2 2018 | $25,000 | -21.9% | 11,000 | 0.0% | 0.02% | -23.1% |
Q1 2018 | $32,000 | +3.2% | 11,000 | 0.0% | 0.03% | 0.0% |
Q4 2017 | $31,000 | -22.5% | 11,000 | 0.0% | 0.03% | -23.5% |
Q3 2017 | $40,000 | – | 11,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
Caption Management, LLC | 855,200 | $701,000 | 0.04% |
Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |